Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 25 | 2017 | 863 | 0.750 |
Why?
|
| Breast Feeding | 1 | 2023 | 126 | 0.710 |
Why?
|
| Genome-Wide Association Study | 11 | 2017 | 423 | 0.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 760 | 0.560 |
Why?
|
| Self Care | 1 | 2016 | 175 | 0.450 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 235 | 0.440 |
Why?
|
| Sleep Apnea, Obstructive | 5 | 2012 | 57 | 0.440 |
Why?
|
| Health Education | 1 | 2016 | 363 | 0.400 |
Why?
|
| Telemedicine | 1 | 2016 | 234 | 0.390 |
Why?
|
| Cardiovascular Diseases | 3 | 2025 | 749 | 0.370 |
Why?
|
| Coronary Disease | 5 | 2014 | 123 | 0.360 |
Why?
|
| Genetic Loci | 6 | 2015 | 104 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2016 | 734 | 0.330 |
Why?
|
| Genotype | 16 | 2017 | 800 | 0.320 |
Why?
|
| Genome, Human | 6 | 2012 | 144 | 0.290 |
Why?
|
| Electrocardiography | 4 | 2016 | 185 | 0.280 |
Why?
|
| Triglycerides | 4 | 2012 | 147 | 0.280 |
Why?
|
| Female | 33 | 2025 | 24698 | 0.280 |
Why?
|
| Cholesterol, HDL | 6 | 2014 | 99 | 0.270 |
Why?
|
| Florida | 3 | 2025 | 478 | 0.270 |
Why?
|
| Middle Aged | 25 | 2025 | 12222 | 0.260 |
Why?
|
| Humans | 42 | 2025 | 43102 | 0.250 |
Why?
|
| Prenatal Care | 1 | 2025 | 93 | 0.220 |
Why?
|
| Stroke | 3 | 2014 | 340 | 0.210 |
Why?
|
| Chromosome Mapping | 6 | 2011 | 199 | 0.210 |
Why?
|
| Patient Readmission | 1 | 2025 | 122 | 0.210 |
Why?
|
| Lipoproteins, HDL | 2 | 2015 | 48 | 0.210 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2023 | 36 | 0.200 |
Why?
|
| Male | 31 | 2025 | 23409 | 0.200 |
Why?
|
| Aged | 19 | 2025 | 8214 | 0.190 |
Why?
|
| Adiponectin | 2 | 2013 | 59 | 0.190 |
Why?
|
| Body Mass Index | 7 | 2015 | 925 | 0.190 |
Why?
|
| Hospitalization | 1 | 2025 | 485 | 0.180 |
Why?
|
| Phenotype | 11 | 2015 | 780 | 0.180 |
Why?
|
| Insulin Resistance | 3 | 2013 | 201 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 497 | 0.170 |
Why?
|
| Adult | 21 | 2025 | 13872 | 0.170 |
Why?
|
| Cholesterol, LDL | 4 | 2014 | 73 | 0.170 |
Why?
|
| Mothers | 1 | 2023 | 215 | 0.170 |
Why?
|
| Obesity | 4 | 2015 | 1151 | 0.160 |
Why?
|
| Infant, Newborn | 1 | 2023 | 972 | 0.160 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2014 | 12 | 0.160 |
Why?
|
| Lipids | 2 | 2012 | 256 | 0.150 |
Why?
|
| Risk Factors | 9 | 2025 | 3994 | 0.150 |
Why?
|
| Infant | 1 | 2023 | 1175 | 0.150 |
Why?
|
| Linkage Disequilibrium | 4 | 2011 | 86 | 0.150 |
Why?
|
| Child | 2 | 2025 | 3443 | 0.140 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 609 | 0.140 |
Why?
|
| Alleles | 7 | 2016 | 352 | 0.140 |
Why?
|
| Genetic Variation | 4 | 2013 | 430 | 0.140 |
Why?
|
| Genetic Association Studies | 5 | 2014 | 118 | 0.120 |
Why?
|
| BRCA2 Protein | 1 | 2016 | 50 | 0.120 |
Why?
|
| Heart Ventricles | 1 | 2016 | 123 | 0.120 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 6 | 0.120 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2006 | 9 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 83 | 0.110 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2014 | 5 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 150 | 0.110 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 10 | 0.110 |
Why?
|
| Quantitative Trait Loci | 2 | 2012 | 88 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 760 | 0.100 |
Why?
|
| Sleep | 1 | 2015 | 185 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 89 | 0.100 |
Why?
|
| Rural Population | 1 | 2016 | 373 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 213 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2015 | 1759 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 148 | 0.100 |
Why?
|
| Endothelin-1 | 1 | 2013 | 57 | 0.100 |
Why?
|
| Genealogy and Heraldry | 1 | 2012 | 5 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2014 | 666 | 0.100 |
Why?
|
| Body Weight | 1 | 2014 | 429 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2004 | 183 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 67 | 0.090 |
Why?
|
| Gene Frequency | 5 | 2012 | 206 | 0.090 |
Why?
|
| Crossing Over, Genetic | 1 | 2011 | 6 | 0.090 |
Why?
|
| Neoplasms | 1 | 2023 | 1377 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2011 | 3 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Cholesterol | 1 | 2012 | 232 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 236 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 65 | 0.080 |
Why?
|
| Alcoholism | 1 | 2013 | 305 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 15 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 3156 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 31 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2011 | 169 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2013 | 1285 | 0.070 |
Why?
|
| Leptin | 1 | 2009 | 118 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2008 | 69 | 0.070 |
Why?
|
| Polysomnography | 3 | 2015 | 43 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2014 | 2853 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2014 | 587 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1092 | 0.060 |
Why?
|
| Pedigree | 4 | 2011 | 94 | 0.060 |
Why?
|
| Young Adult | 4 | 2025 | 5080 | 0.060 |
Why?
|
| Mississippi | 3 | 2010 | 129 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2025 | 102 | 0.060 |
Why?
|
| Adolescent | 4 | 2025 | 6081 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2004 | 7 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 10 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 11 | 0.050 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2004 | 20 | 0.050 |
Why?
|
| Health Surveys | 1 | 2025 | 405 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2010 | 661 | 0.050 |
Why?
|
| Smoking | 1 | 2011 | 1024 | 0.050 |
Why?
|
| Hypertension | 2 | 2025 | 835 | 0.050 |
Why?
|
| Prevalence | 3 | 2017 | 1612 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 2 | 2014 | 35 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2003 | 27 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 278 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 298 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2025 | 863 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2014 | 1063 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 310 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 236 | 0.040 |
Why?
|
| Myocardium | 2 | 2016 | 263 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2014 | 389 | 0.040 |
Why?
|
| United States | 2 | 2025 | 5205 | 0.040 |
Why?
|
| California | 1 | 2023 | 548 | 0.040 |
Why?
|
| Genetics, Population | 2 | 2011 | 121 | 0.040 |
Why?
|
| Lod Score | 3 | 2004 | 13 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 1772 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1723 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2014 | 150 | 0.040 |
Why?
|
| Sex Factors | 3 | 2012 | 1028 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 1154 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2025 | 2544 | 0.040 |
Why?
|
| Gene Expression | 2 | 2012 | 701 | 0.030 |
Why?
|
| Prognosis | 2 | 2011 | 861 | 0.030 |
Why?
|
| Algorithms | 2 | 2011 | 509 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.030 |
Why?
|
| Haplotypes | 2 | 2011 | 197 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2017 | 92 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 455 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 75 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 70 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 82 | 0.030 |
Why?
|
| Microsatellite Repeats | 2 | 2004 | 61 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2014 | 91 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 56 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2004 | 8 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2014 | 75 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 575 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 195 | 0.020 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2013 | 65 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 375 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 287 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 34 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 611 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 490 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 75 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2013 | 259 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 258 | 0.020 |
Why?
|
| Africa, Western | 1 | 2011 | 19 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 74 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 31 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 97 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 115 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 82 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 449 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 87 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1857 | 0.020 |
Why?
|
| Systems Biology | 1 | 2011 | 27 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 42 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 33 | 0.020 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 5 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 81 | 0.020 |
Why?
|
| Georgia | 1 | 2010 | 192 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 114 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 374 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1078 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 266 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1600 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 983 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 307 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2011 | 182 | 0.020 |
Why?
|
| Software | 1 | 2011 | 236 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 293 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 386 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1542 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 327 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 317 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 638 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1009 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 536 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 302 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2004 | 15 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2004 | 31 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 28 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2004 | 37 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 55 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 123 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 201 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 2157 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 1081 | 0.010 |
Why?
|